HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Other Operating Expenses (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Other Operating Expenses came in at $16.4 million in Q2 2021, up 136.15% year-over-year from $6.9 million in Q2 2020, and up 123.21% quarter-over-quarter from -$70.7 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Other Operating Expenses (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Other Operating Expenses for 4 consecutive years, with $16.4 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Other Operating Expenses rose 136.15% year-over-year to $16.4 million in Q2 2021; TTM through Jun 2021 was -$143.5 million, a 18.93% increase from a year earlier, with the FY2025 full-year figure at -$21000.0, down 310.0% from the prior year.
  • Other Operating Expenses was $16.4 million for Q2 2021 at HUTCHMED (China), up from -$70.7 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $122.9 million in Q2 2018 and troughed at -$130.8 million in Q2 2019.
  • A 4-year average of -$13.0 million and a median of -$42.0 million in 2018 frame the typical range for Other Operating Expenses.
  • The widest YoY moves for Other Operating Expenses: up 207.37% in 2019, down 213.01% in 2019.
  • Over 4 years, Other Operating Expenses stood at $42.9 million in 2018, then plunged by 205.82% to -$45.4 million in 2019, then climbed by 0.09% to -$45.4 million in 2020, then soared by 136.15% to $16.4 million in 2021.
  • The last three Other Operating Expenses figures came in at $16.4 million (Q2 2021), -$70.7 million (Q1 2021), and -$45.4 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.35 Bn 198.36 Bn 7.24 Bn
2 Gilead Sciences 181.19 Bn 178.01 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.48 Bn 124.62 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.59 Bn 74.60 Bn 3.93 Bn
5 Argenx Se 61.45 Bn 56.27 Bn 1.37 Bn
6 Moderna 54.89 Bn 49.75 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.21 Bn 30.90 Bn 992.69 Mn
8 Biogen 31.38 Bn 30.10 Bn 1.96 Bn
9 Roivant Sciences 29.81 Bn 29.81 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 16.40 Mn
Mar 31, 2021 -70.67 Mn
Jun 30, 2020 -45.36 Mn
Mar 31, 2020 -43.88 Mn
Dec 31, 2019 -45.40 Mn
Sep 30, 2019 -42.38 Mn
Jun 30, 2019 -130.83 Mn
Mar 31, 2019 44.74 Mn
Dec 31, 2018 42.91 Mn
Sep 30, 2018 37.50 Mn
Jun 30, 2018 122.94 Mn
Mar 31, 2018 -41.67 Mn